I. Dhulia, H. Patel, N. Chauhan, and N. Pardeshi, “FDA’s drug regulatory pathways, its development strategies and regulatory considerations”, Int J Drug Reg Affairs, vol. 9, no. 2, pp. 6-15, Jun. 2021.